Michael King Cannabis Marijuana Palm Springs

Cuomo Administration To Back Adult Use Marijuana Bill

A spokesperson for Gov. Andrew Cuomo says that creating a framework for legalizing adult marijuana use is among the administration’s 2019 legislative priorities.

“The goal of this administration is to create a model program for regulated adult-use marijuana – and we determined the best way to do that was to ensure our final proposal captures the views of everyday New Yorkers,” said Tyrone Stevens, a spokesperson for the Governor. “Now that the listening sessions have concluded, the working group has begun accessing and reviewing the feedback we received and we expect to introduce a formal comprehensive proposal during the 2019 legislative session.”

In July, a Health Department study commissioned by the Governor’s office recommended legalizing adult marijuana use and commerce. It concluded: “A regulated marijuana program enjoys broad support and would have significant health, social justice, and economic benefits. … Regulating marijuana enables public health officials to minimize the potential risks of marijuana use through outreach, education, quantity limits at point of sale, quality control, and consumer protection. … The positive effects of a regulated marijuana market in New York State outweigh the potential negative impacts.”

Original Press Release

Read More
hemp-harvest-micahel-king-cannabis-marijuana-palm-springs

Senate Majority Leader: Farm Bill Will Lift Federal Hemp Ban

Senate Majority Leader Mitch McConnell (R-KY) reaffirmed on Friday that provisions lifting the federal prohibition of hemp will be included in the engrossed language of H.R. 2: The Agriculture Improvement Act of 2018 (aka the 2018 Farm Bill). The must-pass legislation is currently being debated by leadership in conference committee.

“If there’s a Farm Bill, it’ll be in there. I guarantee that” McConnell told reporters. He added: “I don’t want to overstate this – I don’t know if it’s going to be the next tobacco or not – but I do think it has a lot of potential. And as all of you already know, in terms of food and medicine but also car parts. I mean, it’s an extraordinary plant.”

The hemp-specific provisions, which Sen. McConnell included in the Senate version of the bill, amend federal regulations to further expand and facilitate state-licensed hemp production, research, and commerce. The language also for the first time amends the federal Controlled Substances Act of 1970 so that industrial hemp plants containing no more than 0.3 percent THC are no longer classified as a schedule I controlled substance. (See page 1182, Section 12608: ‘Conforming changes to controlled substances act.’)

Read More
cbd-cannabis-bottles-michael-king-cannabis

Plant-Derived Marijuana Medicine Now Available in Us Pharmacies

Washington, DC: Epidiolex, a prescription medicine containing a standardized formulation of the plant-derived cannabidiol (CBD), is now available in pharmacies in all 50 states.

The US Food and Drug Administration approved the product in June for the explicit treatment of two rare forms of severe epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. In September, the US Drug Enforcement Administration reclassified it from Schedule I to Schedule V – the lowest restriction classification available under federal law. Physicians, at their discretion, may also elect to prescribe the medicine “off-label” for medical conditions other than epilepsy.

An annual prescription for Epidiolex is estimated to cost $32,500 per year, a price that the manufacturer says is “in line with other FDA-approved anti-epileptic drugs.”

Epidiolex is the fourth marijuana-based medicine to receive FDA approval – joining dronabinol (aka Marinol), nabilone (aka Cesamet), and liquid synthetic THC (aka Syndros). However, Epidiolex is the first FDA-approved medicine containing plant-derived non-synthetic cannabinoids

Read More
marijuana-mental-health-michael-king-cannabis-palm-springs

Cannabis Use Associated With Improved Outcomes In Bipolar Patients

Cannabis use is associated with an alleviation of clinical symptoms in patients with bipolar disorder and does not negatively impact cognitive performance, according to clinical trial data published in the journal PLoS One.

Investigators with Harvard Medical School, Tufts University, and McLean Hospital in Massachusetts assessed the impact of marijuana use on mood symptomology and cognitive function in patients with bipolar disorder.

Authors reported that marijuana use was associated with lower scores of anger, tension, and depression, as well as higher levels of vigor in BPD patients. Subjects who used marijuana also showed no significant differences in cognitive performance compared to BPD subjects who abstained from the plant. The study is the first clinical trial to assess the impact of cannabis on both mood and neuropsychological performance in BPD patients.

Researchers concluded, “The current study highlights preliminary evidence that patients with BPD who regularly smoked marijuana reported at least short-term clinical symptom alleviation following marijuana use, indicating potential mood-stabilizing properties of marijuana in at least a subset of patients with BPD.”

 


Michael King is an experienced cannabis professional out of Palm Springs with a background in finance, private equity, real estate and consulting. He is currently a principal in one of the leading Cannabis consulting firms in the country Kings Garden

Read More